The noradrenergic paradox: implications in the management of depression and anxiety
Alonso Montoya,1 Robert Bruins,1 Martin A Katzman,2 Pierre Blier3 1Eli Lilly Canada Inc, 2START Clinic for the Mood and Anxiety Disorders, Toronto, 3Mood Disorders Research Unit, Institute of Mental Health Research, University of Ottawa, Ottawa, ON, Canada Abstract: Both major depressive disorder...
Saved in:
Main Authors: | Montoya A, Bruins R, Katzman M, Blier P |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-03-01
|
Series: | Neuropsychiatric Disease and Treatment |
Subjects: | |
Online Access: | https://www.dovepress.com/the-noradrenergic-paradox-implications-in-the-management-of-depression-peer-reviewed-fulltext-article-NDT |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Serotonin Norepinephrine Reuptake Inhibitor Is Associated With Lower Mortality Among Patients Presenting With Takotsubo Cardiomyopathy
by: Garba Rimamskep Shamaki, et al.
Published: (2025-07-01) -
Functioning in patients with major depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia
by: Novick D, et al.
Published: (2016-02-01) -
Treatment discontinuation and tolerability as a function of dose and titration of duloxetine in the treatment of major depressive disorder
by: Harada E, et al.
Published: (2016-01-01) -
Anxiety disorders in patients with infertility
by: A. N. Sulima, et al.
Published: (2025-02-01) -
Long-term administration of escitalopram in patients with social anxiety disorder in Japan
by: Asakura S, et al.
Published: (2016-07-01)